FDA records indicate that there are no current recalls for this drug.
Are you a medical professional?
Trending Topics
Tussin Cf Nighttime Cough And Cold Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
Acyclovir ointment 5% is intended for cutaneous use only and should not be used in the eye.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
Acyclovir ointment 5% is indicated in the management of initial genital herpes and in limited non-life threatening mucocutaneous Herpes simplex virus infections in immunocompromised patients.
History
There is currently no drug history available for this drug.
Other Information
Acyclovir Ointment, USP is a synthetic nucleoside analogue active against herpes viruses. Acyclovir Ointment 5% is a formulation for topical administration. Each gram of Acyclovir Ointment 5% contains 50 mg of acyclovir in a polyethylene glycol (PEG) base.
Acyclovir, USP is a white to off-white, crystalline powder with the molecular formula C8H11N5O3 and a molecular weight of 225. The maximum solubility in water at 37°C is 2.5 mg/mL. The pka’s of acyclovir are 2.27 and 9.25. The chemical name of acyclovir is 9-[(2-Hydroxyethoxy)methyl]guanine; it has the following structural formula:
Sources
Tussin Cf Nighttime Cough And Cold Manufacturers
-
Cvs Pharmacy
Tussin Cf Nighttime Cough And Cold | Mylan Institutional Inc.
Apply sufficient quantity to adequately cover all lesions every 3 hours, 6 times per day for 7 days. The dose size per application will vary depending upon the total lesion area but should approximate a one-half inch ribbon of ointment per 4 square inches of surface area. A finger cot or rubber glove should be used when applying acyclovir ointment to prevent autoinoculation of other body sites and transmission of infection to other persons. Therapy should be initiated as early as possible following onset of signs and symptoms.
Login To Your Free Account